1. Home
  2. CELU vs MLEC Comparison

CELU vs MLEC Comparison

Compare CELU & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • MLEC
  • Stock Information
  • Founded
  • CELU 2016
  • MLEC 2008
  • Country
  • CELU United States
  • MLEC United Kingdom
  • Employees
  • CELU N/A
  • MLEC N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • MLEC Blank Checks
  • Sector
  • CELU Health Care
  • MLEC Finance
  • Exchange
  • CELU Nasdaq
  • MLEC Nasdaq
  • Market Cap
  • CELU 42.2M
  • MLEC 36.0M
  • IPO Year
  • CELU N/A
  • MLEC N/A
  • Fundamental
  • Price
  • CELU $3.86
  • MLEC $1.33
  • Analyst Decision
  • CELU Buy
  • MLEC
  • Analyst Count
  • CELU 1
  • MLEC 0
  • Target Price
  • CELU $6.00
  • MLEC N/A
  • AVG Volume (30 Days)
  • CELU 66.2K
  • MLEC 219.2K
  • Earning Date
  • CELU 10-15-2025
  • MLEC 10-01-2025
  • Dividend Yield
  • CELU N/A
  • MLEC N/A
  • EPS Growth
  • CELU N/A
  • MLEC N/A
  • EPS
  • CELU N/A
  • MLEC N/A
  • Revenue
  • CELU $44,590,000.00
  • MLEC N/A
  • Revenue This Year
  • CELU $23.29
  • MLEC $20.42
  • Revenue Next Year
  • CELU N/A
  • MLEC $30.00
  • P/E Ratio
  • CELU N/A
  • MLEC N/A
  • Revenue Growth
  • CELU 138.11
  • MLEC 170.36
  • 52 Week Low
  • CELU $1.00
  • MLEC $1.20
  • 52 Week High
  • CELU $5.22
  • MLEC $10.47
  • Technical
  • Relative Strength Index (RSI)
  • CELU 60.90
  • MLEC 12.20
  • Support Level
  • CELU $3.52
  • MLEC $1.24
  • Resistance Level
  • CELU $4.01
  • MLEC $1.45
  • Average True Range (ATR)
  • CELU 0.34
  • MLEC 0.25
  • MACD
  • CELU -0.01
  • MLEC -0.03
  • Stochastic Oscillator
  • CELU 64.84
  • MLEC 0.00

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

Share on Social Networks: